{
    "2019-05-07": [
        [
            {
                "time": "",
                "original_text": "去年A股药企销售费用2500亿，研发费用仅340亿，这是行业共性吗？",
                "features": {
                    "keywords": [
                        "A股药企",
                        "销售费用",
                        "研发费用",
                        "行业共性"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "纳川股份参股基金拟7.4亿转让星恒电源部分股权 后者正准备IPO",
                "features": {
                    "keywords": [
                        "纳川股份",
                        "参股基金",
                        "星恒电源",
                        "股权转让",
                        "IPO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物医药公司 加大研发投入成趋势",
                "features": {
                    "keywords": [
                        "生物医药",
                        "研发投入",
                        "趋势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2018年仅25家上市药企亏损 医药行业整体承压",
                "features": {
                    "keywords": [
                        "2018年",
                        "上市药企",
                        "亏损",
                        "医药行业",
                        "承压"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}